Home > Boards > Stock Clubs > Long-Term > Billionaire Boys Club Member Forum (BBCMF)

NNLX DD - 04/27/2006

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Go_Stocks Member Profile
Followed By 183
Posts 10,126
Boards Moderated 9
Alias Born 01/13/04
160x600 placeholder
Go_Stocks   Thursday, 04/27/06 01:55:34 AM
Re: mick post# 128417
Post # of 538966 
NNLX DD - 04/27/2006

Our Sun - burns 700 million tons of hydrogen in every second, in the process, 5 million tons of pure energy is released.

In contrast, about 50 million tons of hydrogen were produced globally in 2005. The economic value of all hydrogen produced is about $135 billion per year. There are two primary uses for hydrogen today. About half is used to produce ammonia (NH3) via the Haber process, which is then primarily used directly or indirectly as fertilizer. The other half of current hydrogen production is used to convert heavy petroleum sources into lighter fractions suitable for use as fuels.

Now imagine the dollar value of hydrogen economy when hydrogen replaces oil as the main energy!

More about hydrogen - misconceptions, myths, and the reality:


Hydrogen blog:



The most abundant element in the universe, hydrogen, also has the highest energy content per unit weight of any known fuel. The bad news is that it rarely occurs by itself in nature, mostly found combined with other elements such as oxygen (for water) and carbon (for fossil fuels) from which it must be harvested. The good news is that once separated, hydrogen is the ultimate clean and highly compacted energy carrier.

Most economists and scientists agree that hydrogen will progressively replace oil in the economy of the future. Unfortunately, the biggest issue is the cost to produce hydrogen. In almost all cases, it needs energy (such as gas or electricity) to produce hydrogen. The cost of generating hydrogen from clean, renewable electricity is in the range of $4.00-5.00 per equivalent gallon of gasoline.

Currently, hydrogen production is 48% from natural gas, 30% from oil, 18% from coal, and 4% from water electrolysis - all at a cost.

Now this is where NNLX comes to play.


NanoLogix, formerly Infectech, Inc., is a biotechnology company founded in 1989 for the development of diagnostic kits for infectious human diseases, microbial remediation of toxic materials, and now the development and commercialization of biological-based technologies for the production of alternative sources of fuel, namely hydrogen.

Through the combination of biotechnology and nanotechnology, NNLX is the first company owns a commercially available patented technology to massively produce hydrogen at the least cost without consuming any kind of energy.

NanoLogix methodology for hydrogen generation is being developed for the limitless production of hydrogen from organic waste and wastewaters. Once fully proven at the large scale Welch production facility, this technology has the potentiality for solving the world energy crisis from any waste organic byproduct, including sewage, and agricultural and food manufacturing waste. The Welch production facility has been finished construction, it is beginning to generate hydrogen as of early April 2006. Dr. Sergey Gazenko, an internationally respected Microbiologist, is hired to fine-tune parameters to increase efficiency and assists commerical demos at the Welch facility.

Last year NanoLogix announced the results of a study that confirmed laboratory proof that its bioreactor system generates hydrogen in high yields via the use and adaptation of its intellectual property. In this study, the bioreactor produced biogas consisting of 50% hydrogen by volume, without any trace of methane, which eliminates an additional costly step.

After last year's study results were revealed, the Company signed a feasibility study with the Department of Environmental Science and Engineering of Gannon University in Erie, PA to develop a bioreactor that utilizes NanoLogix's intellectual assets. The project team compromises a distinguished cohort of scientists and university professors who share a common vision.

In July of last year NanoLogix signed an agreement to generate hydrogen from a scale-up bioreactor system installed at Mobilia Fruit Farms in rural Pennsylvania utilizing waste organic matter from the farm Arrowhead Wines unit.

After the success testing at Mobillia Fruit Farms, a bigger scale-up agreement, to install a hydrogen generation system using Welch Food's waste organic matter, followed shortly. The bioreactor is starting to operate as of early April 2006. Welch, of course, is the world's leading producer of grape and other fruit-based food products, giving NanoLogix virtually unlimited scale-up access to the waste-organics.

Bioreactor is essentially a high-tech fermentation vessel in which microorganisms carry out a biological reaction. In this case production of a hydrogen-rich biogas. The bacterial reaction is self propagating, as the number of bacterias doubles every 24 minutes.

***** There are already a number of major players are interested the technology, such as BP and Northern Power. *****

***** Bulletin Board application: the financial audit is being completed and it's anticipated that the stock should be traded on OTC BB soon. *****

More info about how Nanologix got into hydrogen, comments on their technology vs traditional technologies to extract hydrogen from a newspaper article:




Out of a total of 11 patents worldwide covering the production of hydrogen using the clostridia bacteria, NNLX owns 5 of them. the company has other 22 provisional patents filed covering unique system know-how and features. The newly joined Microbiogist Dr. Sergey Gazenko owns another three patents himself.

Technical References:

Detailed decription of the approach used by Nanologix to generate hydrogen:

The Relative Effectiveness of pH Control and Heat Treatment for Enhancing Biohydrogen Gas Production

Hydrogen Production by Anaerobic Microbial Communities Exposed to Repeated Heat Treatments

Microbial Hydrogen Production


As of 04/18/2006:

48 million shares outstanding and approximitely 20 million shares float.


NanoLogix Names Microbiologist To Hydrogen Generation Technologies Team

Dr. Sergey Gazenko is an internationally respected Microbiologist, he owns three patents in this field. He will assist in investigating its experimental parameters in order to maximize its efficiency. more on Dr. Gazenko: http://www.mibitec.com/docs/NW-5%20(4).doc

NanoLogix Announces the Appointment of New Director

John S. Wisniewski joined Company's Board of Directors. Mr. Wisniewski brings considerable expertise and guidance to NanoLogix in the implementation of international growth initiatives and technology commercialization in addition to lending his longstanding strategic and international business relationships to better the Company's competitive and marketing position of its nanotechnologies, more specifically its medical diagnostic products and hydrogen generation system technologies.

NanoLogix Announces Completion of Welch's Hydrogen Bioreactor Facility and Commencement of Hydrogen Production

The Company has completed the construction of its first commercial hydrogen bioreactor facility at a Welch's Food plant in North East, Pennsylvania. The company also announced that the facility will begin hydrogen generation from Welch's waste organic matter on or about the first of April 2006.

NanoLogix Signs Strategic Agreement for International Alliances

Nutra Pharma Acquires Patents and Licenses for Medical Test Kits

NanoLogix Sells Certain Medical Test-Kit Patents and Extends Licenses on Others

NanoLogix Initiates Activities To Attain Fully Reporting Status

NanoLogix, Inc. (IFEC) Receives Financing Commitment And Strategic Assistance From U.S. Investment Fund

NanoLogix, Inc. (IFEC) Expands Board

NanoLogix, Inc. (IFEC) Management Opposing Hostile Takeover Bid Of Company Patents

NanoLogix, Inc. (IFEC) And Welch Foods Inc. Sign Agreement For Hydrogen Bioreactor

NanoLogix Unveils Advanced DNA Extraction System for Molecular Diagnostics Market

NanoLogix Scales Up its Hydrogen Bio-Reactor

NanoLogix Study Confirms Early Success Of Hydrogen Bioreactor

Nanologix Files Hydrogen Production Patent Application



Price Quote:

50 day EMA is at 0.19, 20 day EMA is at 0.22:

IR Contact Info

NanoLogix Investor Relations

87 Stambaugh Avenue, Suite 2
Sharon, PA 16146 Voice (724) 346-1302
8:00AM - 5:00PM EST Fax (724) 346-9596


NanoLogix is a nano-biotechnology company whose extensive portfolio of patents have application and marketability in the following areas: nanoscale microfluidics for the rapid identification of disease causing pathogens utilizing BioMEMS; production of high value hydrogen from agricultural feedstock, industrial waste water and municipal waste streams; nontoxic induction of apoptosis (a method for inducing a genetically based induction of "cell suicide") in cancer cells utilizing hydrophobic hydrocarbons; and the bio-remediation of air, water and soils of harmful contaminants.

Company website:


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences